Compared side by side
GHK-Cu vs SNAP-8: how they differ
The short answer
Both are skincare peptides with different jobs: GHK-Cu, a copper-binding tripeptide, boosts collagen and speeds wound repair in cell and animal studies, and SNAP-8 copies a piece of the nerve protein SNAP-25, so the small muscles that fold expression lines pull a little less. In a controlled skin trial a GHK-Cu serum cut wrinkle volume more than a control serum; SNAP-8’s evidence is the manufacturer’s own tests and two small studies where it was one ingredient among several. GHK-Cu is also injected, while SNAP-8 is used on the skin, as a serum, a cream or a microneedle patch.
Side by side
| Compared | GHK-Cu | SNAP-8 |
|---|---|---|
| Category | Healing & recovery | Longevity |
| Also known as | Copper Peptide, GHK-Copper, Tripeptide-1 | Acetyl octapeptide-3, Acetyl octapeptide-1, Snap 8 |
| What it is | A small copper-binding peptide found naturally in your blood and widely used in skincare. | A skincare peptide built as a longer version of Argireline. |
| How it works | Tripeptide (glycyl-histidyl-lysine) that binds a copper(II) ion. It occurs naturally in human plasma, and its sequence sits inside type I collagen and the tissue-remodeling protein SPARC. In cell and animal studies, GHK-Cu increased collagen, decorin and glycosaminoglycan production, raised VEGF output by fibroblasts, and damped inflammatory signals such as IL-6. Human evidence is limited to a handful of topical trials, most of them small. | An eight-amino-acid peptide, Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2: Argireline's six with alanine and aspartate added. It copies residues 12–19 of SNAP-25, a protein nerve endings need to release acetylcholine onto muscle, and competes with it for a place in the SNARE complex, the machinery that releases the signal. Less signal means the small muscles that fold expression lines pull a little less. The evidence is lab assays and the manufacturer's own skin tests: no independent trial has tested SNAP-8 on its own, and in lab tests its shorter sibling Argireline barely gets past the skin's outer layer. |
| Commonly reported | Smoother texture and a more even tone after a month or two. Injected GHK-Cu hasn't been tested in a controlled trial. | A subtle softening of crow's feet and forehead lines after about a month of daily use, much milder than a toxin injection; irritation is uncommon. |
| Studied range | Research range: 1–2 mg. Studied in research — not a recommendation. | Research range: 3–10%. The share of the supplier's SNAP-8 solution in a finished serum or cream (its use level), not a dose; the solution itself holds 0.05% of the peptide. Not a recommendation. |
| How often | Daily | Once or twice daily |
| Half-life | Not measured in humans (breaks down quickly in plasma in rat and lab studies) | Not measured (a topical cosmetic ingredient; no human pharmacokinetic data) |
| Route | SubQ injection, Topical application, IM injection | Topical (serum or cream), Microneedle patch |
| Typical run | Often run 8–12 weeks. Can be cycled or run continuously at lower doses. Community consensus is loose. | Used daily as part of a skincare routine rather than in cycles. The published studies that included it ran 4 and 12 weeks. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Injection site reaction, skin irritation (topical), mild flushing | Mild skin irritation (uncommon) |
- Category
- GHK-CuHealing & recovery
- SNAP-8Longevity
- Also known as
- GHK-CuCopper Peptide, GHK-Copper, Tripeptide-1
- SNAP-8Acetyl octapeptide-3, Acetyl octapeptide-1, Snap 8
- What it is
- GHK-CuA small copper-binding peptide found naturally in your blood and widely used in skincare.
- SNAP-8A skincare peptide built as a longer version of Argireline.
- How it works
- GHK-CuTripeptide (glycyl-histidyl-lysine) that binds a copper(II) ion. It occurs naturally in human plasma, and its sequence sits inside type I collagen and the tissue-remodeling protein SPARC. In cell and animal studies, GHK-Cu increased collagen, decorin and glycosaminoglycan production, raised VEGF output by fibroblasts, and damped inflammatory signals such as IL-6. Human evidence is limited to a handful of topical trials, most of them small.
- SNAP-8An eight-amino-acid peptide, Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2: Argireline's six with alanine and aspartate added. It copies residues 12–19 of SNAP-25, a protein nerve endings need to release acetylcholine onto muscle, and competes with it for a place in the SNARE complex, the machinery that releases the signal. Less signal means the small muscles that fold expression lines pull a little less. The evidence is lab assays and the manufacturer's own skin tests: no independent trial has tested SNAP-8 on its own, and in lab tests its shorter sibling Argireline barely gets past the skin's outer layer.
- Commonly reported
- GHK-CuSmoother texture and a more even tone after a month or two. Injected GHK-Cu hasn't been tested in a controlled trial.
- SNAP-8A subtle softening of crow's feet and forehead lines after about a month of daily use, much milder than a toxin injection; irritation is uncommon.
- Studied range
- GHK-CuResearch range: 1–2 mg. Studied in research — not a recommendation.
- SNAP-8Research range: 3–10%. The share of the supplier's SNAP-8 solution in a finished serum or cream (its use level), not a dose; the solution itself holds 0.05% of the peptide. Not a recommendation.
- How often
- GHK-CuDaily
- SNAP-8Once or twice daily
- Half-life
- GHK-CuNot measured in humans (breaks down quickly in plasma in rat and lab studies)
- SNAP-8Not measured (a topical cosmetic ingredient; no human pharmacokinetic data)
- Route
- GHK-CuSubQ injection, Topical application, IM injection
- SNAP-8Topical (serum or cream), Microneedle patch
- Typical run
- GHK-CuOften run 8–12 weeks. Can be cycled or run continuously at lower doses. Community consensus is loose.
- SNAP-8Used daily as part of a skincare routine rather than in cycles. The published studies that included it ran 4 and 12 weeks.
- Evidence
- GHK-CuEmerging: primarily preclinical / limited human data
- SNAP-8Emerging: primarily preclinical / limited human data
- Common side effects
- GHK-CuInjection site reaction, skin irritation (topical), mild flushing
- SNAP-8Mild skin irritation (uncommon)
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
GHK-Cu
- Day 1–14 The first two weeks are groundwork
- Day 14–28 Texture tends to move first
- Day 28–56 This is where results tend to show
- Day 56–84 Weeks 8–12: time for an honest look
- Day 84+ Past the studied window — your read now
SNAP-8
- Day 1–14 The first two weeks are groundwork
- Day 14–28 Expression lines start to soften
- Day 28–56 Weeks 4–8: where the studies looked
- Day 56–84 Weeks 8–12: time for an honest look
- Day 84+ Past the studied window
Together or one or the other
GHK-Cu and SNAP-8 are a common stack: SNAP-8 lists GHK-Cu among its common stacks.
Community · SNAP-8
Why SNAP-8 pairs with GHK-Cu
Two different jobs: SNAP-8 aims at the lines expressions fold, GHK-Cu at the collagen underneath. Commonly reported: both layered in one routine, SNAP-8 on crow's feet and forehead, GHK-Cu across the face.
Questions people ask
How long do GHK-Cu and SNAP-8 last?
The half-life of GHK-Cu is not measured in humans (breaks down quickly in plasma in rat and lab studies). The half-life of SNAP-8 is not measured (a topical cosmetic ingredient; no human pharmacokinetic data).
How often are GHK-Cu and SNAP-8 taken?
GHK-Cu: daily. Routes: SubQ injection, topical application, IM injection. SNAP-8: once or twice daily. Routes: Topical (serum or cream), microneedle patch.
How are GHK-Cu and SNAP-8 dosed in research?
The research range for GHK-Cu is 1–2 mg. Studied in research — not a recommendation. The research range for SNAP-8 is 3–10%. The share of the supplier's SNAP-8 solution in a finished serum or cream (its use level), not a dose; the solution itself holds 0.05% of the peptide. Not a recommendation.
What are the common side effects of GHK-Cu and SNAP-8?
For GHK-Cu, the library lists: injection site reaction, skin irritation (topical), mild flushing. For SNAP-8: mild skin irritation (uncommon).
Are GHK-Cu and SNAP-8 taken together?
GHK-Cu and SNAP-8 are a common stack: SNAP-8 lists GHK-Cu among its common stacks. Two different jobs: SNAP-8 aims at the lines expressions fold, GHK-Cu at the collagen underneath. Commonly reported: both layered in one routine, SNAP-8 on crow's feet and forehead, GHK-Cu across the face.